UBS Asset Management launches U.K. life sciences strategy

UBS Asset Management’s real estate and private markets has launched its first U.K. life sciences property strategy, in partnership with Reef Group, with commitments of £400 million (€464 million/$451 million) from first close investors and a gross development value in excess of £2.5 billion (€2.9 billion/$2.8 billion). Deploying a build-to-core approach, the Article 8 strategy seeks development opportunities in the life sciences sector, with a specific focus on good manufacturing practice (GMP) facilities.

To-date, four sites have been secured within the ‘Golden Triangle’ of London, Oxford and Cambridge, with a forecasted gross development value in excess of £2.5 billion (€2.9 billion/$2.8 billion). This includes